Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$85.40
-2.64-3%
Last update: Oct 6, 4:21 PM
$85.00
-3.04-3.45%
Dianthus Therapeutics Inc (DNTH) Stock Price, Quote, News & History
DNTHNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment,...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Dianthus Therapeutics (NASDAQ:DNTH) through any online brokerage.
Other companies in Dianthus Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Dianthus Therapeutics has a consensus price target of $129.47.
The stock price for Dianthus Therapeutics (NASDAQ: DNTH) is $85 last updated October 6, 2026 at 4:21 PM EDT.
There are no upcoming dividends for Dianthus Therapeutics.
Dianthus Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Dianthus Therapeutics.
Dianthus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
